AVIENT CORP
No enriched coverage for $AVNT in the last 7 days.
No SEC Form 4 filings for $AVNT in the last 30 days.
Avient Corp. is anticipating continued solid sales in 2026, despite facing resin inflation and potential disruptions in the Middle East. The company also expects a recovery in the packaging sector. This outlook comes amidst general market observations of rising polyethylene and other resin prices.
Vanguard Capital Management has reported a 5.24% beneficial ownership in Avient Corp (NYSE: AVNT), holding 4,812,578 shares as of March 31, 2026. This disclosure was made via a Schedule 13G filing, indicating a passive investment strategy. Vanguard maintains sole dispositive power over all reported shares and sole voting power over 696,565 shares.
Avient's GlideTech materials are being utilized in medical catheters. This development was announced by Frank Esposito on January 06, 2026, at 11:46 AM EST. The article highlights the application of these specialized materials within the medical device industry.
